Bernice M Keutzer, CNM in Arlington, IL - Advanced Practice Midwife

Bernice M Keutzer, CNM is a Advanced Practice Midwife based in Arlington, Illinois. Bernice M Keutzer is licensed to practice in Illinois (license number ) and her current practice location is 32169 - 2050 N Ave, Arlington, Illinois. She can be reached at her office (for appointments etc.) via phone at (815) 894-2507.

NPI number for Bernice M Keutzer is 1720081383 and her current mailing address is 32169 - 2050 N Ave, Arlington, Illinois. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1720081383.

Contact Information

	Bernice M Keutzer, CNM
	32169 - 2050 N Ave, Arlington, IL 61312
	(815) 894-2507
	Not Available

Provider's Profile

Full Name	Bernice M Keutzer
Gender	Female
Speciality	Advanced Practice Midwife
Location	32169 - 2050 N Ave, Arlington, Illinois
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1720081383
Provider Enumeration Date: 05/27/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Bernice M Keutzer such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1720081383	NPI	-	NPPES
0632006	Other	IL	BLUECROSS BLUE SHIELD

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
367A00000X	Advanced Practice Midwife	(Illinois)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bernice M Keutzer is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Bernice M Keutzer, CNM 32169 - 2050 N Ave, Arlington, IL 61312 Ph: (815) 894-2507	Bernice M Keutzer, CNM 32169 - 2050 N Ave, Arlington, IL 61312 Ph: (815) 894-2507

News Archive

Eli Lilly to present results of two Phase II trials evaluating ALIMTA in combination with chemotherapy, radiation

Results of two Phase II trials evaluating ALIMTA (pemetrexed for injection) in combination with a platinum chemotherapy and radiation for patients with locally advanced non-small cell lung cancer will be presented by Eli Lilly and Company at the 46th Annual Meeting of the American Society of Clinical Oncology in Chicago, Ill., on June 6, 2010.

Workplace wellness programs improve employer's bottom line

"Who has time?" is a frequent question in response to the suggestion of a medical check-up. Job demands aren't becoming easier to meet in this challenging economy. And there is always a "to-do" list waiting at home. Naturally employees feel these pressures.

Palatin receives FDA clearance to begin PL-3994 Phase 2A trial for asthma treatment

Palatin Technologies, Inc. today announced that the U.S. Food and Drug Administration has cleared Palatin's request to begin a Phase 2A proof-of-concept human trial under an Investigational New Drug application using a subcutaneously administered formulation of PL-3994, an NPR-A agonist compound, in development for treatment of acute exacerbations of asthma.

Researchers make case for standardized analysis of cardiac imaging

For accuracy's sake, medical professionals should use the same software for comparing and analyzing diagnostic heart images taken from different time periods and laboratories, a team of researchers has concluded.

Higher levels of BPA in pregnant mother's blood may contribute to preterm births

Higher concentrations of the common plastics chemical and environmental pollutant Bisphenol A, or BPA, in a pregnant mother's blood may be a contributing factor in preterm births, according to a new study from The University of Texas Medical Branch at Galveston.

Bernice M Keutzer, CNM - Advanced Practice Midwife in Arlington, IL